The attempts to block FAP+ have shown some promises in inducing tumor necrosis and immune-responsive cytotoxicity when combined with immune checkpoint blockade in pancreatic cancer mouse models [42, 43]. The gene discussed is FAP; the disease is familial pancreatic carcinoma.